These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6239430)

  • 1. T suppressor cell function in cyclosporine-treated renal transplant recipients.
    Brando B; Civati G; Busnach G; Grillo C; Minetti L
    Transplant Proc; 1984 Dec; 16(6):1639-41. PubMed ID: 6239430
    [No Abstract]   [Full Text] [Related]  

  • 2. Suppression of second-set rejection by cyclosporine-resistant suppressor cells in a rat renal allograft model.
    Freitas Rodrigues MA; Hutchinson IV; Morris PJ
    Transplant Proc; 1989 Feb; 21(1 Pt 1):365-6. PubMed ID: 2523135
    [No Abstract]   [Full Text] [Related]  

  • 3. Lack of suppressor T cells in renal transplant recipients and activation by aminophylline.
    Shohat B; Shapira Z; Joshua H; Servadio C
    Thymus; 1983 Mar; 5(2):67-77. PubMed ID: 6222520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tempo of induction of W3/25+ suppressor cells in cyclosporine-treated rat cardiac allograft recipients.
    Hall BM; Gurley KE; Dorsch SE
    Transplant Proc; 1987 Feb; 19(1 Pt 1):504. PubMed ID: 2978917
    [No Abstract]   [Full Text] [Related]  

  • 5. Contribution of T-cell subset monitoring of renal transplant recipients in the cyclosporine era.
    Khanuja PS; Toledo-Pereyra LH; Gordon DA; Bandlien KO; Whitten JI
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1852-3. PubMed ID: 2652602
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of suppressor cells in cyclosporine-treated allograft recipients.
    Kerman RH; Flechner SM; Van Buren CT; Lorber MI; Kahan BD
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1580-3. PubMed ID: 2950632
    [No Abstract]   [Full Text] [Related]  

  • 7. Decreased interleukin 2 production and increased LEU 2a-positive suppressor cells in renal transplant patients on triple therapy with mizoribine, cyclosporine A, and prednisolone.
    Okubo M; Kaneko Y; Mizukoshi M; Inoue K; Sato N; Kamata K; Chen XM; Uchida H; Endo T
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1940-3. PubMed ID: 2950635
    [No Abstract]   [Full Text] [Related]  

  • 8. Suppressor cell activity in human renal allograft recipients.
    Hammer C; Land W; Castro LA
    Proc Eur Dial Transplant Assoc; 1981; 18():454-8. PubMed ID: 6460247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppressor cells influence maintenance and reversal of late rejection in indefinitely surviving skin allografts in cyclosporine-treated rats.
    Thornburg LE; Padberg WM; Towpik E; Tilney NL
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):1025-30. PubMed ID: 2968692
    [No Abstract]   [Full Text] [Related]  

  • 10. Follow-up studies on proliferative T cell responses in cadaveric kidney graft recipients under combined immunosuppressive treatment with cyclosporine and prednisone.
    Irschick EU; Niederwieser D; Lochs A; Spielberger M; Gattringer C; Margreiter R; Huber C
    Immunobiology; 1985 Mar; 169(2):128-38. PubMed ID: 3158589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of OKT3 to treat steroid-resistant renal allograft rejection in patients receiving cyclosporine.
    Thistlethwaite JR; Haag BW; Gaber AO; Stuart JK; Aronson AJ; Mayes JT; Lloyd DM; Stuart FP
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1901-4. PubMed ID: 3103294
    [No Abstract]   [Full Text] [Related]  

  • 12. Differentiation of acute rejection from acute cyclosporine nephrotoxicity in renal transplants peripheral T cell subset counts.
    Shen SY; Weir MR; Revie DR; Dagher FJ; Bentley FR; Chretien PB
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1776-9. PubMed ID: 2950634
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of lymphocyte subsets and suppressor cell function in long-term renal transplant recipients.
    Redlich PN; Leapman SB; Marder P; Schmidtke J; Smith EJ; Fineberg N; Filo RS
    Transplant Proc; 1984 Dec; 16(6):1555-7. PubMed ID: 6239424
    [No Abstract]   [Full Text] [Related]  

  • 14. An investigation to assess the potential of CD25highCD4+ T cells to regulate responses to donor alloantigens in clinically stable renal transplant recipients.
    Akl A; Jones ND; Rogers N; Bakr MA; Mostafa A; El Shehawy el M; Ghoneim MA; Wood KJ
    Transpl Int; 2008 Jan; 21(1):65-73. PubMed ID: 17887959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cell subset analysis predicts virus infection but not rejection in cyclosporine A-treated renal allograft recipients.
    Metselaar HJ; Jeekel J; Rothbarth PH; Vaessen LM; Wenting GJ; Weimar W
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2181-2. PubMed ID: 3274486
    [No Abstract]   [Full Text] [Related]  

  • 16. Lymphocyte subpopulations in renal biopsies of transplant patients treated with cyclosporine.
    Lloveras J; Munne A; Serrano S; Corominas JM; Cuevas X; Masramon J
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1660-1. PubMed ID: 3274400
    [No Abstract]   [Full Text] [Related]  

  • 17. Lymphokine production in cyclosporine-treated renal transplant recipients.
    McKenna RM; Rush DN; Bakkestad-Legare P; Jeffrey JR
    Transplant Proc; 1988 Dec; 20(6):1245-7. PubMed ID: 3144073
    [No Abstract]   [Full Text] [Related]  

  • 18. Kidney transplantation by use of splenectomy and transfusions, cadaver haplotype matching, suppressor cell assays, and T-cell monitoring.
    Severyn W; Kyriakides G; Fuller L; Esquenazi V; Flaa C; Olson L; Goldsmith C; Miller J
    Surgery; 1981 Aug; 90(2):364-75. PubMed ID: 6454982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative analysis of regulatory T cells in kidney graft recipients: a relationship with calcineurin inhibitor level.
    Calvo-Turrubiartes M; Romano-Moreno S; García-Hernández M; Chevaile-Ramos JA; Layseca-Espinosa E; González-Amaro R; Portales-Pérez D
    Transpl Immunol; 2009 May; 21(1):43-9. PubMed ID: 19233271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypically and functionally distinct CD8+ lymphocyte populations in long-term drug-free tolerance and chronic rejection in human kidney graft recipients.
    Baeten D; Louis S; Braud C; Braudeau C; Ballet C; Moizant F; Pallier A; Giral M; Brouard S; Soulillou JP
    J Am Soc Nephrol; 2006 Jan; 17(1):294-304. PubMed ID: 16338967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.